Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

CytoDyn reports evidence of HIV suppression with PRO-140

July 16, 2015

McGill University patents anti-GD cancer vaccine

July 6, 2015

NIH grant supports GeoVax's clade C HIV vaccine development program

July 6, 2015

Gilead submits NDA for emtricitabine/rilpivirine/tenofovir alafenamide in HIV

July 2, 2015

MK-1439A enters two new phase III studies in HIV

July 2, 2015

CytoDyn starts first phase III trial of PRO-140 in HIV infection

June 10, 2015

Enrollment complete in Apios's phase I/II trial of bryostatin-1 in HIV infection

June 8, 2015

Cannabis Science and IGXBio to investigate combination of CS-TATI-1 and GenePro in HIV

June 2, 2015

EMA validates MAA for emtricitabine/tenofovir alafenamide fumarate for HIV

May 29, 2015

Johnson & Johnson expands policy to enhance access to darunavir

May 19, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...